n-acetyltryptophan has been researched along with Brain Swelling in 3 studies
N-acetyltryptophan : An N-acetylamino acid that is the N-acetyl derivative of tryptophan.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lewis, KM | 1 |
| Harford-Wright, E | 1 |
| Vink, R | 3 |
| Ghabriel, MN | 1 |
| Donkin, JJ | 1 |
| Nimmo, AJ | 1 |
| Cernak, I | 1 |
| Blumbergs, PC | 1 |
| Turner, RJ | 1 |
| Helps, SC | 1 |
| Thornton, E | 1 |
3 other studies available for n-acetyltryptophan and Brain Swelling
| Article | Year |
|---|---|
NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Astrocytes; Brain Edema; Brain | 2013 |
Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
Topics: Animals; Brain Edema; Brain Injuries; Capillary Permeability; Disease Models, Animal; Enzyme-Linked | 2009 |
A substance P antagonist improves outcome when administered 4 h after onset of ischaemic stroke.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Disease Models, Animal; Drug Administrati | 2011 |